Abstract
In the intermediate hosts, tachyzoites of T. gondii predominate in the acute stage while bradyzoites persist inside tissue cysts with the potential for reactivation. The two stages exhibit different metabolic and antigenic characters. The present study aimed to investigate temporal expression of Toxoplasma SAG1 and BAG1 genes in the brain tissue and the coincident parasitological and histopathological findings in mice models of toxoplasmosis. The study included group A: mice infected with RH strain and sacrificed 7 days post-infection (p.i.); group B: mice infected with RH strain and treated with sulfamethoxazole-trimethoprim (30 mg/kg/day and 150 mg/kg/day respectively) 24 h p.i. until sacrificed at days 5, 10, or 20 post-treatment; group C: mice infected with ME-49 strain and sacrificed at days 7, 27, 47, or 67 p.i; and group D: mice infected with ME-49 strain and received dexamethasone daily starting at day 68 p.i. and scarified at days 6 or 10 post-treatment. All mice were inspected daily for abnormal physical signs. Peritoneal exudate and brain homogenate were examined for detection of Toxoplasma stages. Brain sections were examined histopathologically. SAG1 and BAG1 gene expression was evaluated using reverse transcription real-time polymerase chain reaction and the ΔΔCt method. Results revealed that marked BAG1 upregulation is consistent with detection of Toxoplasma cysts and degenerative changes while predominance of tachyzoites and inflammatory infiltrate is compatible with SAG1 upregulation. The study sheds light on the potential for using stage-specific gene expression pattern as markers for evaluation of toxoplasmosis disease progression in clinical settings.
Similar content being viewed by others
References
Abedalthagafi M, Rushing EJ, Garvin D, Cheson B, Ozdemirli M (2009) Asymptomatic diffuse “encephalitic” cerebral toxoplasmosis in a patient with chronic lymphocytic leukemia: case report and review of the literature. Int J Clin Exp Pathol 3:106–109
Barcia JJ (2007) The Giemsa stain: its history and applications. Int J Surg Pathol 15:292–296
Belal US, Norose K, Aosai F, Mun HS, Ahmed AK, Chen M, Mohamed RM, Piao LX, Iwakura Y, Yano A (2004) Evaluation of the effects of Sulfamethoxazole on Toxoplasma gondii loads and stage conversion in IFN-γ knockout mice using QC-PCR. Microbiol Immunol 48:185–193
Blader IJ, Saeij JP (2009) Communication between Toxoplasma gondii and its host: impact on parasite growth, development, immune evasion, and virulence. APMIS 117:458–476. https://doi.org/10.1111/j.1600-0463.2009.02453.x
Bohne W, Gross U, Ferguson DJ, Heesemann J (1995) Cloning and characterization of a bradyzoite-specifically expressed gene (hsp30/bag1) of Toxoplasma gondii, related to genes encoding small heat-shock proteins of plants. Mol Microbiol 16:1221–1230
Bottari NB, Baldissera MD, Tonin AA, Rech VC, Alves CB, D’Avila F et al (2016) Synergistic effects of resveratrol (free and inclusion complex) and sulfamethoxazole-trimetropim treatment on pathology, oxidant/antioxidant status and behavior of mice infected with Toxoplasma gondii. Microb Pathog 95:166–174. https://doi.org/10.1016/j.micpath.2016.04.002
Buxton D, Maley SW (2008) Toxoplasmosis. In: Edwards S, Schmitt B, Golovko A, El Harrak M, Bandhopadhyay SK, O’Neil B (eds) OIE. World Organization of Animal Health. Manual of diagnostic tests and vaccines for terrestrial animals, 6th edn. Office International Des Epizootes (OIE), France, pp 1286–1295
Cultrera R, Seraceni S, Contini C (2002) Efficacy of a novel reverse transcriptase-polymerase chain reaction (RT-PCR) for detecting Toxoplasma gondii bradyzoite gene expression in human clinical specimens. Mol Cell Probes 16:31–39
Dadimoghaddam Y, Daryani A, Sharif M, Ahmadpour E, Hossienikhah Z (2014) Tissue tropism and parasite burden of Toxoplasma gondii RH strain in experimentally infected mice. Asian Pac J Trop Med 7:521–524. https://doi.org/10.1016/S1995-7645(14)60087-0
Derouin F, Garin YJ (1991) Toxoplasma gondii: blood and tissue kinetics during acute and chronic infections in mice. Exp Parasitol 73:460–468
Dubey J (2008) The history of Toxoplasma gondii - the first 100 years. J Eukaryot Microbiol 55:467–475. https://doi.org/10.1111/j.1550-7408.2008.00345.x
Dumas JL, Pizzolato G, Pechere JC (1999) Evaluation of trimethoprim and sulphamethoxazole as monotherapy or in combination in the management of toxoplasmosis in murine models. Int J Antimicrob Agents 13:35–39
Dzierszinski F, Mortuaire M, Dendouga N, Popescu O, Tomavo S (2001) Differential expression of two plant-like enolases with distinct enzymatic and antigenic properties during stage conversion of the protozoan parasite Toxoplasma gondii. J Mol Biol 309:1017–1027. https://doi.org/10.1006/jmbi.2001.4730
Ferreira da Silva Mda F, Barbosa HS, Gross U, Luder CG (2008) Stress-related and spontaneous stage differentiation of Toxoplasma gondii. Mol BioSyst 4:824–834. https://doi.org/10.1039/b800520f
Gross U, Holpert M, Goebel S (2004) Impact of stage differentiation on diagnosis of toxoplasmosis. Ann Ist Super Sanita 40:65–70
Howe DK, Sibley LD (1995) Toxoplasma gondii comprises three clonal lineages: correlation of parasite genotype with human disease. J Infect Dis 172:1561–1566
Hulínská D, Sýkora J, Zástĕra M (1990) Effect of cortisone on Toxoplasma gondii infection studied by electron microscopy. Folia Parasitol (Praha) 37:207–212
Kiernan JA (1999) Histological and histochemical methods: theory and practice, 3rd edn. Butterworth-Heinemann, Oxford, p 502
Liu J, Bolstad DB, Bolstad ES, Wright DL, Anderson AC (2009) Towards new antifolates targeting eukaryotic opportunistic infections. Eukaryot Cell 8:483–486. https://doi.org/10.1128/EC.00298-08
Liu KY, Zhang DB, Wei QK, Li J, Li GP, Yu JZ (2006) Biological role of surface Toxoplasma gondii antigen in development of vaccine. World J Gastroenterol 12:2363–2368
Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(−Delta C(T)) method. Methods 25:402–408. https://doi.org/10.1006/meth.2001.1262
Mordue DG, Montoy F, La Regina M, Dinarello CA, Sibley LD (2001) Acute toxoplasmosis leads to lethal overproduction of Th1 cytokines. J Immunol 167:4574–4584
Mutsaers HA, Tofighi R (2012) Dexamethasone enhances oxidative stress-induced cell death in murine neural stem cells. Neurotox Res 22:127–137. https://doi.org/10.1007/s12640-012-9308-9
Nicoll S, Wright S, Maley SW, Burns S, Buxton D (1997) A mouse model of recrudescence of Toxoplasma gondii infection. J Med Microbiol 46:263–266
Niedelman W, Gold DA, Rosowski EE, Sprokholt JK, Lim D, Farid Arenas A, Melo MB, Spooner E, Yaffe MB, Saeij JP (2012) The rhoptry proteins ROP18 and ROP5 mediate Toxoplasma gondii evasion of the murine, but not the human, interferon-gamma response. PLoS Pathog 8(6):e1002784. https://doi.org/10.1371/journal.ppat.1002784
Pinto FL, Thapper A, Sontheim W, Lindblad P (2009) Analysis of current and alternative phenol based RNA extraction methodologies for cynobacteria. BMC Mol Bio 10:79. https://doi.org/10.1186/1471-2199-10-79
Rajendran C, Su C, Dubey JP (2012) Molecular genotyping of Toxoplasma gondii from Central and South America revealed high diversity within and between populations. Infect Genet Evol 12:359–368. https://doi.org/10.1016/j.meegid.2011.12.010
Rico-Torres CP, Valenzuela-Moreno LF, Luna-Pastén H, Figueroa-Damián R, Gómez-Toscano V, Hernández-Delgado L, Escobedo-Torres MP, Correa D (2018) High heterogeneity, mixed infections and new genotypes in human congenital toxoplasmosis cases in the mega-metropolis of Central Mexico. Acta Trop 178:124–129. https://doi.org/10.1016/j.actatropica.2017.11.008
Roiko MS, LaFavers K, Leland D, Arrizabalaga G (2018) Toxoplasma gondii-positive human sera recognise intracellular tachyzoites and bradyzoites with diverse patterns of immunoreactivity. Int J Parasitol 48:225–232. https://doi.org/10.1016/j.ijpara.2017.08.016
Schlüter D, Barragan A (2019) Advances and challenges in understanding cerebral toxoplasmosis. Front Immunol 10:242. https://doi.org/10.3389/fimmu.2019.00242
Selseleh M, Modarressi MH, Mohebali M, Shojaee S, Eshragian MR, Azizi E, Keshavarz H (2012) Real-time RT-PCR on SAG1 and BAG1 gene expression during stage conversion in immunosuppressed mice infected with Toxoplasma gondii Tehran strain. Korean J Parasitol 50:199–205. https://doi.org/10.3347/kjp.2012.50.3.199
Selseleh M, Modarressi MH, Shojaee S, Mohebali M, Eshraghian MR, Selseleh M, Keshavarz H (2013) Brain tissue cysts in infected mice with RH-strain of Toxoplasma gondii and evaluation of BAG1 and SAG1 genes expression. Iran J Parasitol 8:40–46
Seng S, Yokoyama M, Suzuki R, Maki Y, Kato M, Lim C (2000) Expression of SAG1 of Toxoplasma gondii in transgenic mice. Parasitol Res 86:263–269
Sibley LD, Boothroyd JC (1992) Virulent strains of Toxoplasma gondii comprise a single clonal lineage. Nature 359:82–85
Skariah S, Mclntyre MK, Mordue DG (2010) Toxoplasma gondii: determinants of tachyzoite to bradyzoite conversion. Parasitol Res 107:253–260. https://doi.org/10.1007/s00436-010-1899-6
Sukthana Y (2006) Toxoplasmosis: beyond animals to humans. Trends Parasitol 22:137–142
Thouvenin M, Candolfi E, Villard O, Klein JP, Kien T (1997) Immune response in a murine model of congenital toxoplasmosis: increased susceptibility of pregnant mice and transplacental passage of Toxoplasma gondii are type 2-dependent. Parassitologia 39:279–283
Tolba MM, El-Taweel HA, Khalil SS, Hazzah WA, Heshmat MG (2014) Genotype analysis of T. gondii strains associated with human infection in Egypt. Parasitol Res 113:1563–1569. https://doi.org/10.1007/s00436-014-3801-4
Tomita T, Bzik DJ, Ma YF, Fox BA, Markillie LM, Taylor RC, Kim K, Weiss LM (2013) The Toxoplasma gondii cyst wall protein CST1 is critical for cyst wall integrity and promotes bradyzoite persistence. PLoS Pathog 9:e1003823. https://doi.org/10.1371/journal.ppat.1003823
Vidal JE (2019) HIV-related cerebral toxoplasmosis revisited: current concepts and controversies of an old disease. J Int Assoc Provid AIDS Care 18:2325958219867315. https://doi.org/10.1177/2325958219867315
Villard O, Cimon B, L'Ollivier C, Fricker-Hidalgo H, Godineau N, Houze S, Paris L, Pelloux H, Villena I, Candolfi E (2016) Serological diagnosis of Toxoplasma gondii infection: recommendations from the French National Reference Center for Toxoplasmosis. Diagn Microbiol Infect Dis 84:22–33. https://doi.org/10.1016/j.diagmicrobio.2015.09.009
Wei HX, Wei SS, Lindsay DS, Peng HJ (2015) A systematic review and meta-analysis of the efficacy of anti-Toxoplasma gondii medicines in humans. PLoS One 10(9):e0138204. https://doi.org/10.1371/journal.pone.0138204
Yano A, Mun HS, Chen M, Norose K, Hata K, Kobayashi et al (2002) Roles of IFN-γ on stage conversion of an obligate intracellular protozoan parasite, Toxoplasma gondii. Int Rev Immunol 21:405–421
Ye S, Xia N, Zhao P, Yang J, Zhou Y, Shen B, Zhao J (2019) Micronemal protein 13 contributes to the optimal growth of Toxoplasma gondii under stress conditions. Parasitol Res 118:935–944. https://doi.org/10.1007/s00436-018-06197-3
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Additional information
Section Editor: Xing-Quan Zhu
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
ESM 1
(DOCX 268 kb)
Rights and permissions
About this article
Cite this article
El-Sayad, M.H., Hussein, N.A., Kazem, A.H. et al. Temporal expression of Toxoplasma stage-specific genes in brain tissue: coincidence with parasitological and histopathological findings in mice models. Parasitol Res 119, 2299–2307 (2020). https://doi.org/10.1007/s00436-020-06723-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00436-020-06723-2